Clinical Trial Update: Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder [Phase 2]

View source ↗

Summary

Clinical trial update announcing a Phase 2 study of TJ0113 capsules for depressive disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• TJ0113 capsules

Snippet

Sponsor: Hangzhou PhecdaMed Co., Ltd. | Conditions: Depression | Phase 2 | Status: RECRUITING